ArticleEndocrine2025
Quantitative sensory testing and skin biopsy for neuropathy assessment in Portuguese patients with type 1 diabetes: an exploratory study.
Article in Endocrine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeSkin biopsy (SB) is considered the gold standard for detecting Small Fiber Neuropathy (SFN), a common complication of Diabetes Mellitus Type 1 (DM1). However, its invasive nature makes it less accessible for routine screening. Therefore, this study aims to analyze the diagnostic accuracy of Quantitative Sensory Testing (QST) in detecting SFN, using SB as reference.
methodsA cross-sectional study was performed based on a sample of 49 adult patients with DM1 and 11 Healthy Controls. All participants underwent QST and SB. Associations between z-scores of QST parameters and SFN classified by SB were estimated by logistic regression. The cut-offs for SFN were defined by Receiver Operating Characteristic (ROC) analysis using the Youden index criterion.
resultsSFN was present in a large majority of patients with DM1, particularly among those with painful diabetic neuropathy (94.7%, p < 0.001). Among QST parameters, Cold Detection Threshold (CDT), Warm Detection Threshold (WDT), Cold Pain Threshold (CDT), Heat Pain Threshold (HPT), Thermal Sensory Limen (TSL), Mechanical Detection Threshold, Mechanical Pain Threshold (MPT) and Vibration Detection Threshold were associated with the diagnosis of SFN. The predictive model including z-scores of CDT, WDT, CDT, HPT, TSL and MPT had the best accuracy (area under the ROC curve: 0.876; cut-off: 0.541; sensitivity: 90%; specificity: 81%).
conclusionSeveral QST parameters were associated with SFN and their combination demonstrated a good diagnostic accuracy. This non-invasive method may help identify and track SFN, ultimately improving patient management and early intervention strategies. Future studies should integrate nerve conduction studies to provide a comprehensive assessment of large fiber involvement in diabetic neuropathy.
Indexed as
Identifiers
41461620What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.